Sugi Predict

Sugi Predict / Compounds / SCHEMBL973787

SCHEMBL973787

SCHEMBL973787

CCCCCCCC(=O)OCCN

nearest known ligand 0.77

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ DGKA P23743 1/20 0.77
▸ MAPT P10636 2/20 0.66
▸ ALDH1A1 P00352 2/20 0.66
▸ THRB P10828 1/20 0.66
▸ CNR1 P21554 1/20 0.66
▸ DNM1 Q05193 1/20 0.62
▸ HTR2C P28335 1/20 0.61
▸ PRSS1 P07477 1/20 0.58
▸ PRSS2 P07478 1/20 0.58
▸ PRSS3 P35030 1/20 0.58
▸ PAM P19021 2/20 0.58
▸ TSHR P16473 1/20 0.55
▸ NAAA Q02083 1/20 0.53
▸ CYP1A2 P05177 1/20 0.53
▸ LMNA P02545 3/20 0.53
▸ KDM4E B2RXH2 1/20 0.51
▸ DUSP3 P51452 1/20 0.51
▸ MEN1 O00255 1/20 0.51
▸ KMT2A Q03164 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL976601 1.00 DGKA (0.77) DGKAMAPTALDH1A1THRBCNR1
SCHEMBL19376381 1.00 DGKA (0.77) DGKAMAPTALDH1A1THRBCNR1
SCHEMBL19402727 1.00 DGKA (0.77) DGKAMAPTALDH1A1THRBCNR1
SCHEMBL10346903 1.00 DGKA (0.77) DGKAMAPTALDH1A1THRBCNR1
SCHEMBL3338674 1.00 DGKA (0.77) DGKAMAPTALDH1A1THRBCNR1
SCHEMBL5933172 1.00 DGKA (0.77) DGKAMAPTALDH1A1THRBCNR1
SCHEMBL974095 1.00 DGKA (0.77) DGKAMAPTALDH1A1THRBCNR1
SCHEMBL2678233 1.00 DGKA (0.77) DGKAMAPTALDH1A1THRBCNR1
SCHEMBL19397840 1.00 DGKA (0.77) DGKAMAPTALDH1A1THRBCNR1
SCHEMBL3344674 0.98 DGKA (0.74) DGKAMAPTALDH1A1THRBCNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115418644-A Corrosion inhibitor, preparation method and application thereof in water-based cleaning agent 湖南金裕环保科技有限公司 2022-12-02 — — CN claimed
US-9493583-B2 Anionic polysaccharides functionalized by a hydrophobic acid derivative ADOCIA (FR) 2016-11-15 — — US claimed
CN-118317944-A Acyclic lipids and methods of use thereof 雷纳嘉德医疗管理公司 2024-07-09 — — CN disclosed
CN-118234707-A Cyclic lipids and methods of use thereof 雷纳嘉德医疗管理公司 2024-06-21 — — CN disclosed
CN-117940426-A DNA-dependent protein kinase inhibitors, compositions and uses thereof 英特利亚治疗股份有限公司 2024-04-26 — — CN disclosed
CN-117916375-A Modified guide RNAs for gene editing comprising internal linkers 因特利亚治疗公司 2024-04-19 — — CN disclosed
CN-113039174-B Ionizable amine lipids 英特利亚治疗股份有限公司 2023-11-17 — — CN disclosed
CN-116535381-B Cationic lipid compound having five-membered ring acetal structure, composition containing same and use 北京悦康科创医药科技股份有限公司 2023-10-17 — — CN disclosed
CN-116887841-A Nanomaterials comprising ester-linked acetals 比姆医疗股份有限公司 2023-10-13 — — CN disclosed
CN-116782913-A Nanomaterials comprising acetals 比姆医疗股份有限公司 2023-09-19 — — CN disclosed
CN-116685332-A Nanomaterial comprising carbonate 比姆医疗股份有限公司 2023-09-01 — — CN disclosed
US-20190262366-A1 ETHANOLAMINE-BASED LIPID BIOSYNTHETIC COMPOUNDS, METHOD OF MAKING AND USE THEREOF CANTUARIA, GUILHERME H.C. 2019-08-29 — — US disclosed
US-20170273995-A1 ETHANOLAMINE-BASED LIPID BIOSYNTHETIC COMPOUNDS, METHOD OF MAKING AND USE THEREOF CANTUARIA, GUILHERME H.C. 2017-09-28 — — US disclosed
US-20170273995-A1 ETHANOLAMINE-BASED LIPID BIOSYNTHETIC COMPOUNDS, METHOD OF MAKING AND USE THEREOF CANTUARIA, GUILHERME H.C. 2017-09-28 — — US disclosed
US-20170273995-A1 ETHANOLAMINE-BASED LIPID BIOSYNTHETIC COMPOUNDS, METHOD OF MAKING AND USE THEREOF CANTUARIA, GUILHERME H.C. 2017-09-28 — — US disclosed
US-9493583-B2 Anionic polysaccharides functionalized by a hydrophobic acid derivative ADOCIA (FR) 2016-11-15 — — US disclosed
CN-102300586-A Stable Pharmaceutical Composition Containing At Least One Monoclonal Antibody And At Least One Amphiphilic Polysaccharide Comprising Hydrophobic Substituents — 2011-12-28 — — CN disclosed
US-20110172166-A1 Anionic polysaccharides functionalized by a hydrophobic acid derivative ADOCIA (FR) 2011-07-14 — — US disclosed
US-20110014189-A1 Stable pharmaceutical composition comprising at least one monoclonal antibody and at least one amphiphilic polysaccharide comprising hydrophobic substituents ADOCIA (FR) 2011-01-20 — — US disclosed
US-20100146845-A1 ADDITIVE COMPOSITIONS FOR CORRECTING OVERTREATMENT OF CONDUCTIVITY ADDITIVES IN PETROLEUM FUELS INNOSPEC FUEL SPECIAL TIES LLC (US) 2010-06-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110172166-A1 Anionic polysaccharides functionalized by a hydrophobic acid derivative ALG1, CD44, FUT6 DGKA 2291/4885MAPT 2444/4885ALDH1A1 3350/4885
US-20190262366-A1 ETHANOLAMINE-BASED LIPID BIOSYNTHETIC COMPOUNDS, METHOD OF MAKING AND USE THEREOF PHOSPHO1, SGMS2, CHKB DGKA 171/4885MAPT 4121/4885ALDH1A1 657/4885
US-20170273995-A1 ETHANOLAMINE-BASED LIPID BIOSYNTHETIC COMPOUNDS, METHOD OF MAKING AND USE THEREOF PHOSPHO1, SGMS2, CHKB DGKA 171/4885MAPT 4121/4885ALDH1A1 657/4885
US-20110014189-A1 Stable pharmaceutical composition comprising at least one monoclonal antibody and at least one amphiphilic polysaccharide comprising hydrophobic substituents ALG1, SIGLEC7, PIGS DGKA 2922/4885MAPT 866/4885ALDH1A1 1444/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback